Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer

The impact of ctDNA changes after chemotherapy on the clinical outcomes of patients with metastatic colorectal cancer (mCRC) remains unclear. The present study evaluated the clinical implications of the early change in ctDNA levels as a predictor of objective response and clinical outcome in mCRC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Osumi, Hiroki, Shinozaki, Eiji, Yamaguchi, Kensei, Zembutsu, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874682/
https://www.ncbi.nlm.nih.gov/pubmed/31758080
http://dx.doi.org/10.1038/s41598-019-53711-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874682/
https://www.ncbi.nlm.nih.gov/pubmed/31758080
http://dx.doi.org/10.1038/s41598-019-53711-3

Ejemplares similares